Manufacturer Dengue IgM ELISA Test Device

Product Main Parameters

Common Product Specifications

Product Manufacturing Process

The Manufacturer Dengue IgM Elisa Test Device is produced adhering to stringent quality control standards. The manufacturing process involves coating microtiter plates with dengue virus antigens, ensuring specificity and accuracy. Quality checks are performed at each stage to guarantee batch consistency. The enzyme-linked immunosorbent assay technique is employed, a well-documented method for antibody detection, allowing for high-throughput and reliable results. Given its adherence to ISO13485 and FDA guidelines, the device offers robust performance in diverse clinical settings.

Product Application Scenarios

The Dengue IgM ELISA Test Device is critical in regions facing dengue outbreaks, particularly in tropical and subtropical climates. Its ability to detect IgM in the early stages of infection aids in timely intervention, crucial for controlling disease spread. Healthcare providers utilize the test for surveillance and managing patient care efficiently, helping prevent complications associated with dengue fever. As highlighted in numerous studies, accurate serological testing forms the backbone of epidemiological assessments and public health strategies against dengue.

Product After-Sales Service

• 24/7 customer support helpline
• Comprehensive user manual and troubleshooting guide
• Replacement policy for defective kits

Product Transportation

• Secure packaging ensuring temperature stability
• International shipping options available
• Real-time tracking services

Product Advantages

• Rapid processing and results within hours
• High specificity and sensitivity
• Capable of handling large sample volumes

Product FAQ

• What is the shelf life of the Dengue IgM ELISA test?

  The Manufacturer Dengue IgM Elisa Test Device has a shelf life of 12 months when stored at 2-8°C. Proper storage conditions ensure the test maintains its effectiveness throughout this period.

• How soon can the test detect dengue after infection?

  The test can detect IgM antibodies typically within a few days post-symptom onset, making it an effective tool for early diagnosis.

• Are there any limitations to the Dengue IgM ELISA?

  While highly effective, the test may show cross-reactivity with other flaviviruses, potentially leading to false positives in areas where these viruses circulate.

• Can the ELISA test replace RT-PCR?

  The Dengue IgM ELISA is complementary to RT-PCR. While ELISA detects antibodies, RT-PCR identifies viral RNA. Together, they provide a comprehensive diagnostic approach.

• What are the implications of a positive result?

  A positive result indicates the presence of dengue-specific IgM antibodies, suggesting a recent or ongoing infection. Clinical correlation and further investigation are recommended.

• Is the test suitable for mass screening?

  Yes, the test's design allows for processing multiple samples simultaneously, making it ideal for large-scale surveillance in endemic areas.

• How does the test ensure accuracy?

  The Manufacturer Dengue IgM Elisa incorporates control standards and an internal procedural check to maintain accuracy and reliability of results.

• What training is required to perform the test?

  Basic laboratory training in handling serum samples and ELISA protocols is recommended for accurate execution of the test.

• Are results affected by improper specimen storage?

  Yes, improper storage can degrade antibodies, affecting the accuracy of results. Adhering to recommended storage conditions is crucial.

• How are false positives managed?

  False positives may occur due to cross-reactivity. Confirmatory tests and clinical evaluation help manage such scenarios effectively.

Product Hot Topics

• Development of Dengue IgM ELISA by Leading Manufacturer

  The development of the Dengue IgM Elisa Test Device by Laihe Biotech reflects cutting-edge research and innovation in diagnostic technology. By securing multiple international patents, the company continues to enhance testing capabilities for infectious diseases. This device exemplifies their commitment to quality, evidenced by global certifications such as ISO13485 and FDA approval.

• The Role of ELISA in Infectious Disease Management

  ELISA tests, like the Dengue IgM Elisa, are pivotal in managing infectious diseases by identifying the presence of antibodies. The test's utility in early diagnosis aids healthcare providers in implementing timely treatment and prevention strategies, significantly impacting public health outcomes.

• Addressing Emerging Dengue Strains with Advanced Detection

  As dengue evolves, having a reliable test like the Manufacturer Dengue IgM Elisa is crucial. It enables healthcare systems to combat emerging strains by facilitating early detection and response, underscoring its importance in disease management.

• Understanding the Science Behind ELISA

  The enzyme-linked immunosorbent assay (ELISA) is a cornerstone of diagnostic testing, leveraging antigen-antibody interactions to deliver accurate results. The Manufacturer Dengue IgM Elisa harnesses this technology, providing high-throughput and reliable diagnostics.

• Impact of Global Certifications on Diagnostic Device Reliability

  Global certifications like FDA and ISO13485 signify a product's reliability and quality, crucial for diagnostic devices. The Manufacturer Dengue IgM Elisa's compliance with these standards reflects its effectiveness and reliability in clinical settings worldwide.

• The Future of Dengue Diagnosis: Technological Innovations

  Technological advancements in diagnostic testing, such as the Manufacturer Dengue IgM Elisa, pave the way for faster, more accurate disease detection. These innovations are vital in addressing global health challenges posed by vector-borne diseases like dengue.

• Enhancing Public Health through Early Disease Detection

  Early detection tests like the Dengue IgM Elisa are instrumental in public health efforts, allowing for prompt intervention and better disease control. Their ability to offer quick results facilitates the implementation of effective healthcare strategies.

• Challenges in Detecting Dengue in Flavivirus Co-circulation Areas

  Regions where flaviviruses co-circulate face diagnostic challenges due to potential cross-reactivity. The Manufacturer Dengue IgM Elisa addresses these challenges, offering specificity and accuracy critical for effective disease management.

• Improving Diagnostic Accuracy with Complementary Testing

  Combining the Dengue IgM Elisa with other testing methodologies, such as RT-PCR, enhances diagnostic accuracy. This complementary approach ensures comprehensive evaluation, crucial for patient management and epidemiological assessments.

• Success Stories: Using ELISA in Dengue-Endemic Regions

  In dengue-endemic regions, the Manufacturer Dengue IgM Elisa has played a crucial role in managing outbreaks, facilitating early diagnosis, and guiding targeted interventions. This success underscores its value in global health initiatives.

Image Description